Alzheimer's Disease: Drugs
Commons · Question 20108 · Tabled 13 Dec 2024 · Department of Health and Social Care · Official record
Answered 19 Dec 2024
Question
Asked by Freddie van Mierlo
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the adequacy of NICE methodology in appraising innovative medicines for licensed for Alzheimer's Disease.
Answer
Answered by Karin Smyth, 19 Dec 2024
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes it uses to develop recommendations on whether new medicines represent a clinically and cost-effective use of National Health Service resources. The N...